Membrane events related to transmitter release in mouse motor nerve terminals captured by ultrarapid cryofixation.
The sequence of structural changes occurring in the presynaptic membrane during transmitter release was studied at the mouse neuromuscular junction using the combined quick-freezing and cryosubstitution techniques. The mouse levator auris longus (LAL) muscle was stimulated by two means: either, chemically, by soaking 5 min before freezing in a physiological solution containing 25 mM potassium chloride or, electrically, by applying, 10 ms before freezing, a single supramaximal stimulus to the nerve-muscle preparation treated with 50 microM 3,4-diaminopyridine (3,4-DAP) and 100 microM (+)tubocurarine. In both cases, the preparations were maintained at approximately 5 degrees C, 5 min prior to freezing, in order to prolong nerve membrane changes. In most experiments, tannic acid (0.1%) was added to the substitution medium for better preservation of membranes. The different steps of warming in the substitution medium were strictly controlled from -90 degrees C to 4 degrees C. When fixed under chemical stimulation, the presynaptic membrane appeared very sinuous and synaptic vesicles were seen apposed to specialized sites facing subjunctional folds. When submitted to a single electrical stimulus, after treatment with 3,4-diaminopyridine, features of synaptic vesicle fusion were observed at these specialized sites which appear similar by their morphology, their macromolecular organization (already described) and their functional changes to active zones of the frog neuromuscular junction. Other images suggested that with 3,4-diaminopyridine which causes a pronounced and long-lasting release of transmitter, some vesicles collapse after exocytosis instead of being locally reformed by endocytosis.
Velasco
M E
ME
Institut des Neurosciences CNRS-Université Pierre et Marie Curie, Département de Neurobiologie des Signaux Intercellulaires, Paris, France.
Pécot-Dechavassine
M
M
D015761:4-Aminopyridine / Q000031:analogs & derivatives / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism; D000077770:Amifampridine; D000818:Animals; D004558:Electric Stimulation; D005404:Fixatives; D005615:Freezing; D047348:Hydrolyzable Tannins; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D009045:Motor Endplate / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure*; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D013572:Synaptic Vesicles / Q000502:physiology / Q000648:ultrastructure; D014403:Tubocurarine / Q000494:pharmacology
D005404:Fixatives; D047348:Hydrolyzable Tannins; D018377:Neurotransmitter Agents; D015761:4-Aminopyridine; D000109:Acetylcholine; D000077770:Amifampridine; D011188:Potassium; D014403:Tubocurarine